Feeling sick?

Use the Symptom Checker to check your symptoms

Add this to your profile
Banner for leaf pages 2

Deferasirox (Exjade)

Also known as Exjade

Deferasirox (marketed as Exjade) is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose.

Source: Wikipedia

Estimated Total Cost: $4742.43 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed deferasirox to treat sickle cell anemia, anemia, myelodysplastic syndrome, and hemochromatosis.

Ajax-loader Loading...